15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes

Since clinical experience with biphasic insulin aspart 30 (BIAsp 30) in type 2 diabetes mellitus (T2DM) was reviewed in 2012 after 10 years of use worldwide, additional studies have been published that highlight new aspects, including use in real-world populations. Evidence from 35 new studies confi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liebl, Andreas, Mohan, Viswanathan, Yang, Wenying, Strojek, Krzysztof, Linjawi, Sultan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833912/
https://www.ncbi.nlm.nih.gov/pubmed/29468559
http://dx.doi.org/10.1007/s40268-018-0228-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833912/
https://www.ncbi.nlm.nih.gov/pubmed/29468559
http://dx.doi.org/10.1007/s40268-018-0228-x

Ejemplares similares